Anaplastic pilocytic astrocytoma

From Libre Pathology
Revision as of 13:52, 17 October 2022 by Jensflorian (talk | contribs) (→‎General: tumor is outdated)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Anaplastic pilocytic astrocytoma, abbreviated APA, is an outdated tumor terminology. Most of these tumors are now classified either as High-grade astrocytoma with piloid features, Pleomorphic xanthoastrocytoma or as Glioblastoma, IDH-wildtype.

General

  • High-grade astrocytoma - behaviour corresponded in older classifications to WHO Grade III.
  • Some authors prefered the designation pilocytic astrocytoma with anaplastic features.
  • Less than 2% of all pilocytic astrocytomas.[1]
  • De novo cases in the setting of neurofibromatosis 1 reported.
  • Many tumors have history of previous radiation.

Old microscopic criteria

Features:[2]

  • At least 4 mitoses/10 high power fields - see HPFitis.
  • Hypercellularity.
  • Necrosis +/-.
  • Pilocytic like (biphasic) - most common.
    1. Eosinophilic granular bodies +/-.
  • Small cell (32%)
  • Epithelioid cells (15%)
  • Fibrillary areas resembling diffuse astrocytoma.

IHC

Features:[3]

  • GFAP +ve (fibres).
  • p53: +ve.
  • KI-67: high 25%.
  • ATRX loss may be present.[4]
  • IDH1 (R132H) -ve.
  • H3F3A (K27M) -ve.

See also

References

  1. Rodriguez, FJ.; Scheithauer, BW.; Burger, PC.; Jenkins, S.; Giannini, C. (Feb 2010). "Anaplasia in pilocytic astrocytoma predicts aggressive behavior.". Am J Surg Pathol 34 (2): 147-60. doi:10.1097/PAS.0b013e3181c75238. PMID 20061938.
  2. Rodriguez, FJ.; Scheithauer, BW.; Burger, PC.; Jenkins, S.; Giannini, C. (Feb 2010). "Anaplasia in pilocytic astrocytoma predicts aggressive behavior.". Am J Surg Pathol 34 (2): 147-60. doi:10.1097/PAS.0b013e3181c75238. PMID 20061938.
  3. Rodriguez, FJ.; Scheithauer, BW.; Burger, PC.; Jenkins, S.; Giannini, C. (Feb 2010). "Anaplasia in pilocytic astrocytoma predicts aggressive behavior.". Am J Surg Pathol 34 (2): 147-60. doi:10.1097/PAS.0b013e3181c75238. PMID 20061938.
  4. Ebrahimi, A.; Skardelly, M.; Bonzheim, I.; Ott, I.; Mühleisen, H.; Eckert, F.; Tabatabai, G.; Schittenhelm, J. (Jun 2016). "ATRX immunostaining predicts IDH and H3F3A status in gliomas.". Acta Neuropathol Commun 4 (1): 60. doi:10.1186/s40478-016-0331-6. PMID 27311324.